3//SEC Filing
Abuse Deterrent Pharma, LLC 3
Accession 0001567619-19-015922
CIK 0000786947other
Filed
Aug 6, 8:00 PM ET
Accepted
Aug 7, 2:50 PM ET
Size
5.7 KB
Accession
0001567619-19-015922
Insider Transaction Report
Form 3
Abuse Deterrent Pharma, LLC
10% Owner
Holdings
Convertible Promissory Note
Exercise: $0.16From: 2019-06-28→ Common Stock (37,500,000 underlying)Warrant
Exercise: $0.01From: 2019-06-28Exp: 2024-06-28→ Common Stock (10,000,000 underlying)
Footnotes (2)
- [F1]The note is convertible, at the election of the Reporting Person, at any time prior to repayment of the Note and matures on July 1, 2023.
- [F2]Excludes any interest accruing on the Note, which is convertible at the election of the Reporting Person.
Documents
Issuer
ACURA PHARMACEUTICALS, INC
CIK 0000786947
Entity typeother
IncorporatedKY
Related Parties
1- filerCIK 0001782327
Filing Metadata
- Form type
- 3
- Filed
- Aug 6, 8:00 PM ET
- Accepted
- Aug 7, 2:50 PM ET
- Size
- 5.7 KB